Kainate receptors (KARs) are a subtype of ionotropic glutamate receptor, which are tetrameric assemblies of combinations of five possible subunits (GluK1--5) [@b1]. They are highly expressed and widely distributed throughout the central nervous system (CNS) where they play key roles in the regulation of neurotransmission and neuronal network activity [@b2]. Presynaptic KARs modulate neurotransmitter release, postsynaptic KARs mediate excitatory neurotransmission and extrasynaptic KARs are involved in controlling neuronal excitability [@b1].

In addition to direct ligand-gated ion channel activity, KARs also signal through a pertussis toxin-sensitive G-protein pathway leading to intracellular Ca^2+^ release and protein kinase C (PKC) activation. This metabotropic KAR pathway is involved in the presynaptic facilitation of glutamate release and in the downregulation of GABA release [@b3],[@b4]. Postsynaptic metabotropic KARs increase neuronal excitability by inhibiting the hyperpolarization caused by the postspike potassium current I(sAHP) [@b5].

Interestingly, the functional consequences of KAR activation depend on the strength of stimulation and the developmental stage of the neurons. For example, low to moderate activation of presynaptic KARs at rat hippocampal mossy fibres enhances synaptic transmission, whereas strong KAR stimulation depresses transmission [@b6]. In immature rat hippocampal slices KAR activation enhances the motility of axonal filopodial, whereas in mature slices KAR activation inhibits motility [@b7].

Dendritic spines are small, often mushroom-shaped protrusions that contain specialized postsynaptic machinery and compartmentalize the signalling molecules required for efficient excitatory synaptic transmission and plasticity [@b8]. We have shown previously that diffuse surface-expressed, non-spine-associated KARs are rapidly internalized following sustained KAR or transient NMDAR stimulation. Surprisingly, however, a less intense, transient kainate application causes an initial decrease followed by a slow and long-lasting increase in surface-expressed KARs to levels significantly greater than those prior to the agonist challenge. We interpreted those data to suggest that transient agonist activation of KARs evokes increased levels of exocytosis after the initial endocytosis [@b9].

We have also reported that internalized GluK2-containing KARs undergo differential activity-dependent sorting into recycling or degradative pathways depending on the endocytotic stimulus [@b10]. Recycling endosomes are highly dynamic microtubule-associated vesiculo-tubular membrane structures that mediate recycling in dendritic spines [@b11],[@b12] and their membrane is defined by the presence of the small GTPase Rab11 [@b13],[@b14].

In this study, we provide a mechanistic explanation for kainate-evoked increases in surface-expressed KARs at the postsynaptic membrane. We show that the increase is independent of *de novo* exocytosis or lateral diffusion. Rather, it is mediated by enhanced KAR recycling, which is accompanied by the accumulation of transferrin-positive vesicles in spines and blocked by dominant-negative Rab11 or primaquine. Furthermore, we show that these effects of KAR activation depend on G-protein signalling pathway. Taken together, our results reveal a novel metabotropic autoregulatory feedback pathway in which low or moderate levels of activation can increase KAR surface expression in dendritic spines by regulating receptor recycling.

Results
=======

Transient kainate activation decreases KAR mobility and increases colocalization with PSD95
-------------------------------------------------------------------------------------------

We investigated the dynamics of SEP-GluK2 in the plasma membrane of 20--25 DIV hippocampal neurons by fluorescence recovery after photobleach (FRAP) ([Figure 1](#fig01){ref-type="fig"}A). L689560 (5 mM), GYKI 53655 (40 mM) and tetrodotoxin citrate (TTX, 0.5 μM) were included to block NMDARs, AMPARs and suppress activity-dependent release of glutamate, respectively. Application of kainate (10 μM for 3 min) immediately before photobleaching the spine dramatically decreased the time course and extent of fluorescence recovery compared with the prebleached level of fluorescence (normalized to 100% in [Figure 1](#fig01){ref-type="fig"}B). The difference between the prebleach level of fluorescence and the recovered steady state after bleaching, achieved at ∼200 seconds, reflects the immobile fraction of SEP-GluK2. This is the proportion of photobleached SEP-GluK2 that is either anchored and does not diffuse away or diffuses only at very slow rates. This may be due to direct or indirect tethering of KARs to the cytoskeleton and/or their confinement in membrane microdomains [@b15]. In control conditions, the steady state after FRAP was 96.2 ± 3.7% of the prebleached fluorescence. Following kainate application, however, the steady state after FRAP was 63.89 ± 2.4%. These results demonstrate that 10 μM kainate for 3 min increases the anchoring of surface-expressed SEP-GluK2 in spines.

![Kainate activation retains KARs in spines\
A) Representative glow-scale images of FRAP timeline for SEP-GluK2 in a dendritic spine. The spine indicated by the circle in the second image was photobleached. To confirm that the FRAP was from surface-expressed SEP-GluK2 we briefly washed cells in pH 6.0 buffer to eclipse the surface of fluorescence. Scale bar 2 µm. B) Normalized traces of SEP-GluK2 FRAP in spines in control (black circles) and kainate (10 μM, 3 min, white circles)-treated neurons. Cells were bleached immediately after kainate treatment (*t* = 0 min). Mean ± SEM. Left, histograms showing SEP-GluK2 recovery in control and after kainate application. Recovery was defined as the mean value of the steady-state level (400--800 seconds). C) Fitted curves and histograms showing the diffusion coefficients in spines under control and kainate conditions. For (B) and (C) the data are the mean ± SEM, *n* = 25--36 spines, p \< 0.001. D) Left panel, colocalization of endogenous GluK2 (red) and PSD95 (green). Right panel, colocalization of the NR1 (red) and PSD95 (green). Scale bar 2 µm, p \< 0.001. Histograms show Pearson\'s coefficient for the colocalization ± SEM.](tra0014-0810-f1){#fig01}

As detailed in the *Materials and Methods*, we fitted these FRAP data to a Brownian diffusion model that incorporates the possibility of an immobilized fraction [@b15] ([Figure 1](#fig01){ref-type="fig"}C). The SEP-GluK2 diffusion coefficient was sixfold slower after kainate application (control = 0.06 ± 0.012 µm^2^/second and kainate = 0.011 ± 0.004 µm^2^/second). Thus, there is a kainate-dependent increase in the proportion of KARs that are immobilized and/or a decrease in the rate of movement of KARs that remain mobile. Furthermore, these results indicate a marked increase in the proportion of SEP-GluK2 retained at spines after kainate application and that, compared with non-stimulated controls, KARs accumulate in spines over the time. Consistent with this, kainate application increased colocalization of endogenous GluK2/3 with the postsynaptic marker PSD95 after 3 min of kainate stimulation and 20 min of recovery ([Figure 1](#fig01){ref-type="fig"}D, left), with no change in the extent of NR1/PSD95 colocalization ([Figure 1](#fig01){ref-type="fig"}D, right; see also [Figure S1](#SD1){ref-type="supplementary-material"}A,B, Supporting Information).

Kainate activation increases GluK2 in spines but not in the dendritic shaft
---------------------------------------------------------------------------

Time-lapse experiments demonstrated that transient kainate stimulation increased surface SEP-GluK2 in spines, whereas levels were stable, or slightly reduced, in dendritic shaft regions. These results indicate that the kainate-invoked immobilization of SEP-GluK2 occurs specifically in spines ([Figure 2](#fig02){ref-type="fig"}A,B).

![Kainate activation increases GluK2 in spines but not in dendrite shaft\
A) Representative images showing kainate-induced (10 μM, 3 min) increase of surface SEP-GluK2 in the spine head but not in the shaft. Scale bar 2 µm. B) Normalized fluorescence intensity values of spine/shaft pairs in time-lapse experiments after control (bottom panel) and kainate (upper panel). Mean ± SEM, *n* = 17--22 pairs spine/shaft per neuron from 8 to 10 neurons. C) Representative images showing the distribution of GluK2 (green) in the spine and the adjacent dendritic shaft in control and kainate-treated neurons expressing mCherry. Scale bar 1 µm. Line graphs show representative examples of the profiles of peak GluK2 fluorescence in the spine and adjacent shaft. For details of the analysis, see *Materials and Methods* and [Figure S1](#SD1){ref-type="supplementary-material"}C. D) Top, histogram of mean fluorescence ratio of spines and shafts in control and kainate-treated cells. Values were taken from the fluorescence intensity peaks of the GluK2 fluorescence profile across the spine/shaft. Values above 1 indicate higher GluK2 fluorescence in the spine compared with the shaft. p \< 0.001. Bottom, scatter graph showing the distribution of all individual GluK2 spine/shaft ratios in control and kainate conditions. Values above 1 indicate higher GluK2 fluorescence in the spine compared with the shaft. *n* = 59--61 spine/shaft pairs.](tra0014-0810-f2){#fig02}

We next analysed the distribution of native KARs in spines and adjacent dendritic shaft. We fixed cultured hippocampal neurons and used a gentle 0.05% digitonin plasma membrane permeabilization protocol to allow immunostaining with a specific C-terminal targeted anti-GluK2/3 antibody [@b16]--[@b18]. We measured the localization of KARs in spines and adjacent shaft in two ways. First, we delineated a region of interest (ROI) with a box that longitudinally divided the spine and adjacent shaft in half and both halves were analysed as described previously [@b19]. We then captured the profile of maximum GluK2 antibody fluorescence within these areas by line scans and normalized the peak value to mCherry fluorescence (see *Materials and Methods* and [Figure S1](#SD1){ref-type="supplementary-material"}C). This provided a profile of peak GluK2 distribution along the axis of spine and through the dendrite ([Figure 2](#fig02){ref-type="fig"}C,D). Second, we analysed the same raw image data by defining the area of the spine and an adjacent region of shaft, averaging the fluorescence in both regions and normalized this to the mCherry fluorescence in the same area (see *Materials and Methods* and [Figure S1](#SD1){ref-type="supplementary-material"}D). Both methods of analysis yielded similar results and demonstrate increased levels of KARs in spines following kainate activation.

Increased KAR surface expression in spines requires receptor recycling
----------------------------------------------------------------------

The increase in GluK2/3 immunofluorescence in spines could be caused by increases in intracellular GluK2 or surface-expressed GluK2, or both. To determine if the increase was due to insertion directly into the spine membrane, we visualized newly inserted SEP-GluK2 in live neurons. We used an anti-GFP-Alexa 594 antibody, which recognizes SEP. In non-permeabilized cells the antibody has access only to the epitope in surface-expressed SEP-GluK2 \[[Figure 3](#fig03){ref-type="fig"}A, see also [Figure S1](#SD1){ref-type="supplementary-material"}[@b20],[@b21]\]. The rates of insertion in the spine and shaft were calculated from the increase in antibody labelling after 10 min (see *Materials and Methods*). Using this approach, we quantified the fraction of surface-expressed SEP-GluK2 that had not previously been present at the cell surface. This analysis excludes lateral diffusion and increases in fluorescence because of reinsertion/recycling of SEP-GluK2 labelled during the first anti-GFP-Alexa 594 incubation ([Figure S1](#SD1){ref-type="supplementary-material"} [@b20]). The sensitivity of the experiment to detect *de novo* SEP-GluK2 in the plasma membrane was confirmed by preincubation of the cells with cycloheximide (CHM, [Figure 3](#fig03){ref-type="fig"}B,C, bottom panel). Importantly, kainate did not increase the exocytosis of GluK2 into the spines compared with the dendrites ([Figure 3](#fig03){ref-type="fig"}B,C), indicating that the kainate-induced increase in spines ([Figure 2](#fig02){ref-type="fig"}A--D) is not mediated by the exocytosis of naïve or newly synthesized receptors.

![Acute increases in synaptic GluK2 do not involve insertion of *de novo* KARs\
A) Schematic of protocol (see *Materials and Methods* for details). SEP-GluK2 inserted during the 10-min incubation interval illustrated by difference between the labelling at *t* = 0 and *t* = 10 min. Receptors previously surface expressed bound to unlabelled antibody and recycled back to the surface are not detected in this assay. Newly labelled receptors in each incubation are shown in red. Thus, receptors labelled at *t* = 0 are indicated as purple at *t* = 10, and the newly labelled receptors in red. B) Profiles of SEP-GluK2 insertion into spine and shaft. Images show SEP-GluK2 labelled with anti-GFP-Alexa 594 antibody at *t* = 0 and *t* = 10 in control cells, after kainate application or following 2-h incubation with cycloheximide. Note that in these experiments SEP is used as an extracellular epitope tag and only Alexa 594 fluorescence is shown and quantified. Scale bar 1 µm, *n* = 22--26 pairs spine/shaft per neuron from 10 to 12 neurons. C) Histograms showing the rate of insertion (calculated as Δ*F*/*F*~0~) in the spine and shaft of control cells (upper panel), kainate-treated cells (middle panel) or incubated with cycloheximide (bottom panel).](tra0014-0810-f3){#fig03}

To further explore the possible contributions from newly synthesized KARs, we preincubated SEP-GluK2-expressing neurons with cycloheximide for 2 h and then challenged with kainate. As expected, kainate elicited a transient increase in SEP-GluK2 surface expression in spines, but not in the dendritic shaft ([Figure 4](#fig04){ref-type="fig"}A,B). Further, this increase in spines corresponded to the initial phase of the biphasic increase in SEP-GluK2 shown in [Figure 2](#fig02){ref-type="fig"}. After ∼10 min, however, the kainate-invoked increase in spine SEP-GluK2 fluorescence started to decline in cycloheximide-treated neurons. These results suggest that the initial increase in GluK2 does not require new protein but that GluK2 synthesis is necessary to maintain raised GluK2 levels in spines.

![Endosomal recycling mediates increased synaptic GluK2\
A) Transient increase in SEP-GluK2 in the spine (arrowheads at 400 seconds in lower panels), but not in the adjacent shaft, of kainate-treated neurons preincubated with cycloheximide for 2 h. Scale bar 1 µm. B) Quantification of normalized fluorescence intensity values of spine/shaft pairs showing that kainate increases synaptic GluK2 in the absence of new protein synthesis. Data = mean ± SEM, *n* = 20--28 pairs spine/shaft per neuron from 10 to 15 neurons. C) Representative images showing that the recycling blocker primaquine prevents kainate-evoked increases in surface SEP-GluK2. Scale bar 3 µm. D) Normalized fluorescence intensity values of spine/shaft pairs in control (left panel) and kainate condition (right panel). Mean ± SEM, *n* = 23--29 pairs spine/shaft from 12 to 15 neurons. Kainate application is indicated by the red bar and primaquine by the blue bar.](tra0014-0810-f4){#fig04}

Next, we tested if recruitment of already surface-expressed receptors from outside the spine could account for increased levels of postsynaptic SEP-GluK2. We used a protocol combining FRAP and fluorescence loss in photobleaching (FLIP) to monitor SEP-GluK2 in neurons preincubated with cycloheximide to remove any contribution from newly synthesized receptors. This FRAP/FLIP protocol specifically measures SEP-GluK2 exocytosis because it prevents any component of FRAP from already surface-expressed SEP-GluK2 fluorescence by repetitively photobleaching a section of dendrite proximal to the ROI ([Figure S2](#SD1){ref-type="supplementary-material"}A,C, green line) [@b22]--[@b24]. Because lateral membrane diffusion is excluded, the time taken for fluorescence recovery is dramatically slowed in FRAP-FLIP experiments (minutes) compared with FRAP experiments (seconds). Kainate stimulation can potentiate the mobility of dendrites and protrusions [@b7]. To minimize these confounding influences, we selected a relatively large ROI and performed partial bleaching to 60--80% of the prebleach fluorescence. The kainate-induced increase in SEP-GluK2 surface expression in spines was still observed in these FRAP/FLIP experiments, indicating that increased synaptic SEP-GluK2 is unlikely because of redistribution of surface-expressed SEP-GluK2 from proximal to more distal areas ([Figure S2](#SD1){ref-type="supplementary-material"}).

Primaquine selectively inhibits membrane protein recycling but not endocytosis [@b25] and we have shown previously that it blocks GluK2 recycling in neurons [@b21]. In control cells, primaquine caused a gradual decline in SEP-GluK2 fluorescence in spines compared with the shaft ([Figure 4](#fig04){ref-type="fig"}D,E). Spine fluorescence decreased by 24.65 ± 0.25%, whereas the shaft decreased by 9.45 ± 0.29%. These values are the mean fluorescence between *t* = 1000 and 1200 seconds as a percentage of the mean baseline fluorescence determined prior to KA or vehicle addition (−240 to 0 seconds). This suggests that the contribution of constitutive recycling is higher in spines than in shaft. In kainate-treated neurons, there was no primaquine-induced decline in SEP-GluK2 fluorescence in the shaft (103.94 ± 0.328%). Furthermore, primaquine applied 2 min after transient kainate stimulation not only blocked but also reversed the SEP-GluK2 increase in spines (44.54 ± 0.18%, [Figure 4](#fig04){ref-type="fig"}D,E). Taken together, these results confirm that regulation of KAR recycling underpins the kainate-invoked increase in synaptic KARs.

To investigate the endosomal mechanisms involved in synaptic KAR recycling, we used wild-type and dominant-negative Rab proteins. Specifically, we investigated Rab4, Rab8 and Rab11. Rab4 mediates recycling from early endosomes back into the plasma membrane, whereas Rab11 promotes the activity-dependent translocation of endosomes from the shaft to the head of the spine [@b26]--[@b28]. Overexpression of wild-type Rab11 dramatically enhanced, and dominant-negative Rab11 completely prevented, the kainate-induced increase in spine GluK2/3 immunoreactivity ([Figure 5](#fig05){ref-type="fig"}A,B). In contrast, overexpression of dominant-negative Rab4 or Rab8, which is associated with delivery from trans-Golgi membranes, had no effect ([Figure S3](#SD1){ref-type="supplementary-material"}). These results indicate that the agonist-evoked increase in GluK2 in the spine is dependent on Rab11-positive recycling endosomes.

![Increased synaptic GluK2 requires Rab11-dependent recruitment of recycling endosomes\
A) Representative images of GluK2 immunoreactivity (green) and the fluorescence profile along transects through the spine and shaft of neurons expressing RFP-Rab11 or RFP-Rab11-dominant-negative (Rab11dn). Scale bar 1 µm. B) Histogram of mean GluK2 fluorescence ratio of spines and shafts in RFP-Rab11 or RFP-Rab11dn-expressing neurons. p \< 0.001, *n* = 19--32 pairs spine/shaft from 12 to 15 neurons. C) Time-lapse experiments showing the translocation of Alexa-transferrin-labelled recycling endosomes from the shaft to the head of the spine after kainate application. Cells were imaged before (*t* = −200 seconds) and after kainate treatment (*t* = 0). Arrows indicate the movement of endosomes into the spine from the shaft. Scale bar 2 µm. D) Representative images showing GluK2 colocalization with Tf-A595 endosomes in the spine following kainate application. Scale bar 1 µm. E) Quantification of the proportion of Tf-A595 endosomes containing GluK2 in the spine head, *n* = 12--19 cells. F) Classification of Tf-A595 endosomes according to their position in the head (a), neck (b), shaft (c), head and neck (d), neck and shaft (e) and head--neck--shaft (f) in cells overexpressing GFP, Rab11 or Rab11dn in control and 20 min after kainate application (3 min). *n* = 20--40 spines per neuron from 11 to 14 neurons. Scale bar 1 µm.](tra0014-0810-f5){#fig05}

Synaptic stimulation elicits the redistribution of transferrin-positive recycling endosomes from the dendritic shaft to the spine head [@b29],[@b30]; therefore, we tested if this process could underlie the increase in spine KARs following transient kainate activation. Neurons overexpressing GFP were incubated with fluorescent transferrin (Tf-A595) and the distribution of Tf-labelled endosomes monitored in control and kainate-treated cells ([Figure 5](#fig05){ref-type="fig"}C). Kainate application triggered a rapid translocation of Tf-A595 endosomes from the shaft into the spine head of live cells. We next analysed Tf-A595 colocalization with GluK2 in fixed neurons to determine the proportion of GluK2-containing endosomes in the spine head ([Figure 5](#fig05){ref-type="fig"}D,E). In control neurons, 47.1 ± 9.6% of the Tf-endosomes in the spine head contained GluK2, whereas in kainate-stimulated neurons 89.2 ± 5.5% of the Tf-endosomes in the spine head contained GluK2.

We also determined the effects of overexpressing wild-type or dominant-negative Rab11 on Trf-A595 endosomes. In control neurons, 63% of spines had Trf-A595-labelled recycling endosomes at their base and 15% at their head ([Figure 5](#fig05){ref-type="fig"}F). In contrast, 20 min after kainate stimulation, only 20% of spines had recycling endosomes in their base and 41% at their head. Thus, recycling endosomes translocate from the base of the spine into the spine after kainate stimulation. Overexpression of dominant-negative Rab11 completely blocked this kainate-induced translocation of recycling endosomes into the spine. Taken together, these results demonstrate that transient kainate stimulation increases KAR surface expression in spines via a mechanism that involves recruitment of recycling endosomes into the spine through a Rab11-dependent pathway.

The increase in GluK2 surface expression requires PKC
-----------------------------------------------------

KAR surface expression and recycling are regulated by PKC phosphorylation of GluK2 [@b9],[@b18],[@b31]. Therefore, we investigated the role of PKC in kainate-induced increases in GluK2 surface expression by surface biotinylation. As expected, kainate stimulation caused an increase in surface GluK2 with no change in the total amount of GluK2 protein. Consistent with our previous data, this redistribution of GluK2 to the plasma membrane was prevented by incubation with primaquine. In addition, we show that it is also prevented by preincubation with the PKC inhibitor chelerythrine ([Figure 6](#fig06){ref-type="fig"}A,B), which we have shown previously block PKC-dependent recycling of GluK2-containing KARs [@b21]. Note, however, that addition of chelerythrine immediately after stimulation did not prevent the kainate-induced increase of surface GluK2, indicating that PKC activity is required to trigger the increase but not for the maintenance of surface GluK2.

![Increased surface expression of GluK2 requires PKC activation\
A) Representative biotinylation and immunoblots showing surface expression of GluK2 after kainate treatment. Application of chelerythrine (CLT) after kainate stimulation did prevent the kainate-induced increase of KARs in the plasma membrane (lanes 3 and 4), but preincubation with chelerythrine (lanes 7 and 8) or primaquine (PMQ, lanes 5 and 6) blocked the kainate-induced increase of KARs in the surface. Lower panel shows the KAR immunoreactivity in the lysates (input). B) Quantification of data shown, mean ± SEM, *n* = 4.](tra0014-0810-f6){#fig06}

Recycling, endosomal trafficking and metabotropic actions of KARs
-----------------------------------------------------------------

As KARs can signal via PKC-sensitive metabotropic pathways [@b4],[@b32] we investigated if this regulates postsynaptic KAR recycling. Inhibition of PLC, G-protein activation and blocking intracellular Ca^2+^ release by incubating cells with BAPTA-AM \[but not preventing Ca^2+^ influx by chelating extracellular calcium with ethylenediaminetetraacetic acid (EDTA)\] all prevented the kainate-induced increase of surface GluK2 ([Figure 7](#fig07){ref-type="fig"}A,B). As reported previously [@b33], pretreatment with pertussis toxin increased the levels of both surface-expressed and total GluK2. Kainate, however, did not further increase the surface/total ratio of GluK2 in pertussis toxin-treated cells. These results indicate that G-protein activation and intracellular calcium signalling are involved in the kainate-induced increase in synaptic KARs.

![Increased GluK2 recycling requires metabotropic actions of KARs\
A) Representative immunoblots showing GluK2 surface expression after kainate treatment. BAPTA-AM (lanes 5 and 6) but not EDTA [@b3],[@b4] blocked the kainate-induced increase of KARs in the plasma membrane. Preincubation with the phospholipase C inhibitor (U73122, lanes 7 and 8) or the G-protein inhibitor pertussis toxin PTS (lanes 9 and 10) blocked the kainate-induced increase of KARs in the surface. *n* = 3 (note that PTS increased GluK2 in the total fraction and in the plasma membrane). *n* = 4. B) Histogram showing quantification of normalized data represented in A. C) Immunoblots showing that replacing extracellular Na^+^ with *N*-methyl-[d]{.smallcaps}-glucamine does not block the kainate-induced increase of KARs in the plasma membrane. *n* = 3. D) Histogram of quantified data represented in C. E) Immunolocalization of GluK2 (red) and PSD95 (green) in control neurons and neurons 20 min after kainate application (KA). Also shown are neurons treated with EDTA ± KA, BAPTA-AM ± KA, U73122 ± KA, chelerythrine (CLT) ± KA and pertussis toxin (PTS) ± KA. F) Histogram indicating Pearson\'s coefficient for the degree of colocalization of GluK2 and PSD95 under the conditions shown in A--B. Mean ± SEM. p \< 0.001, *n* = 11--15 neurons. G) Percentage of spines with TfR-A495-positive endosomes in the spine head or in the dendritic shaft at the spine base. Mean ± SEM, p \< 0.001 for control versus kainate and EDTA versus EDTA kainate and p \> 0.1 for the rest of the treatments. *n* = 18--20 spines per neuron from 10 to 12 neurons.](tra0014-0810-f7){#fig07}

We next replaced Na^+^ with an equimolar concentration of the non-permeant cation *N*-methyl-[d]{.smallcaps}-glucamine [@b3] to block the ionotropic function of KARs. Lowering the extracellular concentration of Na^+^ did not block the kainate-induced increase of surface GluK2 ([Figure 7](#fig07){ref-type="fig"}C,D), demonstrating that this process is largely independent of KAR channel activity.

Finally, we measured the degree of colocalization of GluK2 and PSD95 in randomly selected fields of view (see *Materials and Methods*) in cultured neurons. Consistent with the biotinylation data, blocking intracellular Ca^2+^, PKC, PLC or G-protein activation prevented the kainate-induced increase of GluK2 colocalization with PSD95 ([Figure 7](#fig07){ref-type="fig"}E,F). Furthermore, the kainate-dependent translocation of recycling endosomes from the shaft to the spine head was prevented by blockade of the metabotropic signalling pathway ([Figure 7](#fig07){ref-type="fig"}G).

Discussion
==========

KARs are unusual in that the same receptor complex signals via both ionotropic and metabotropic pathways. This was first shown by electrophysiological studies using concentrations of kainate that do not activate inward currents (for reviews, see 1, 32, and 34). Here, we demonstrate that this non-canonical metabotropic pathway mediates a positive feedback system that results in increased levels of surface-expressed postsynaptic GluK2-containing KARs.

Relatively low-level kainate stimulation (in our culture 10 μM, 3 min) elicits KAR recycling, whereas longer kainate stimulation (10 μM, 30 min) causes endocytosis and degradation [@b9],[@b10]. We interpret our results to suggest that metabotropic KAR signalling could represent a priming system to recruit KARs to synapses under conditions of low activity to increase synaptic gain. At active synapses, where KARs are subjected to higher levels of the endogenous neurotransmitter glutamate, ionotropic signalling leads to KAR internalization. Thus, this bidirectional feedback system constitutes an elegant scaling mechanism to increase KARs at weakly active synapses decreases KARs at strongly active synapses.

PKC dynamically regulates KARs trafficking and is required to maintain KAR synaptic responses in different brain regions [@b35]--[@b37]. Both sustained and transient agonist effects on KARs are dependent on PKC activation [@b10]. The GluK2 C-terminal residues Ser-846 and Ser-868 are phosphorylated by PKC and this regulates KAR biosynthesis and maturation, and also endocytosis from the plasma membrane [@b31]. Further, PKC phosphorylation of Ser-868 regulates SUMOylation of Lys-886, which leads to KAR endocytosis and degradation [@b18]. PKC phosphorylation of Ser-868 in the absence of SUMOylation, however, enhances GluK2 recycling between endosomal compartments and the plasma membrane. Thus, SUMOylation may act as the switch between PKC-dependent enhancement or reductions in the surface expression of KARs [@b21].

Our data indicate that the initial increase in surface GluK2 involves redistribution of existing GluK2 but that maintenance requires new protein synthesis. The FLIP/FRAP experiments demonstrate that the increase in synaptic GluK2 is not via lateral diffusion of already surface-expressed GluK2 from the soma or the proximal segment of the dendrite. Rather, we show that the increase requires the translocation of recycling endosomes into the spine head. It should be noted, however, that our data do not completely exclude a contribution of KARs inserted into the membrane at extrasynaptic sites diffusing to adjacent synapses [@b30],[@b38]. Transient kainate stimulation recruits recycling endosomes into spines. Under resting conditions, ∼10% of Tf-containing endosomes are present in the spine head compared with ∼67% after kainate stimulation. Consistent with the synaptic activity-dependent translocation of Tf vesicles [@b39], this redistribution of recycling endosomes is Rab11 dependent. Thus, low or moderate kainate activation appears to increase the endosomal recycling in the spine via a metabotropic pathway that requires PKC, G-protein activation and Rab11. These findings also support a role for kainate stimulation in raised levels of protein transport and membrane insertion, consistent with overexpression of KAR and/or KAR activation causing pronounced effects on axonal and dendritic outgrowth, development of philopodia and increased spine density [@b7],[@b9],[@b40]--[@b42].

In summary, we demonstrate that kainate activation elicits an increase in surface expression of GluK2-containing KARs in dendritic spines. This occurs via KAR metabotropic signalling that promotes KAR recycling in spines by the Rab11-dependent recruitment of recycling endosomes into the spine head. This represents a previously unsuspected KAR autoregulatory pathway that provides additional flexibility to synaptic regulation and will likely have important physiological and pathophysiological consequences in the control of neuronal excitability and synaptic transmission. Furthermore, KARs are expressed in a range of polarized cells in addition to neurons [@b43] and the processes we define here likely represent generalized KAR trafficking mechanisms for other tissues outsidethe CNS.

Materials and Methods
=====================

Dissociated neuronal cultures
-----------------------------

Rat embryonic hippocampal (for imaging) or cortical (for biochemistry) neuronal cultures were prepared as previously described [@b18]. Briefly, hippocampi from E18 Wistar rats of either sex were dissected and the neurons dissociated by enzymatic digestion with trypsin for 15 min and mechanical dissociation. Cells were then plated at a density of 500 000 per 35-mm dish or 50 000 onto 22-mm glass coverslips coated with poly-[l]{.smallcaps}-lysine (Sigma). The culture medium was composed of neurobasal medium (Gibco) supplemented with horse serum (10%), B27 (Gibco) and 2 mM glutamine. On the second day, the media were changed for neurobasal medium supplemented with B27 and neurons were then fed each week with this glutamine-free medium until use (20--25 days *in vitro*).

Image acquisition
-----------------

Images were captured using Zeiss LSM 510 META confocal system or an Ultraview Spinning Disk system (Perkin Elmer). Fluorescence was excited using 63× oil objective (numerical aperture, 1.4) by 488-nm laser light, and emission was detected through a 505-nm long-pass filter (or 505- to 550-nm bandpass filter when imaged simultaneously with Alexa 594; Zeiss LSM). Imaging of Alexa 594-labelled anti-GFP antibody fluorescence used 543-nm excitation and a long-pass 600-nm emission filter.

Time-lapse assays
-----------------

Neurons were infected with Sindbis virus-expressing SEP-GluK2 and imaged the next day or transfected using Lipofectamine 2000 and used for experiments 5--6 days later. Cells were imaged in modified aCSF (in mM: 119 NaCl, 10 glucose, 25 HEPES pH 7.4, 2 NaHCO~3~, 2.5 KCl, 1 NaH~2~PO~4~, 2.5 CaCl~2~, 1.3 MgSO~4~ saturated with 95% O~2~ and 5% CO~2~) at 37°C containing L689560 (5 μM), GYKI 53655 (40 μM) and TTX (0.5 μM) to block NMDARs, AMPARs and suppress activity-dependent release of glutamate, respectively. A total of 1--10 μM kainate was applied for 3 min and the neurons were washed twice and incubated in aCSF without kainate for 20 min at 37°C. Time series were collected as image stacks that were compressed into two dimensions using a maximum projection algorithm and filtered using a 3 × 3 low-pass kernel. Any images that exhibited movements in the *x*, *y* or *z* planes during the experiments were discarded.

The dynamics of surface-expressed SEP-GluK2 were measuring using surface fluorescence at the indicated time points and after an acid wash at the end of the experiment. The residual fluorescence after the acid wash was subtracted from each time point and then normalized to the fluorescence before kainate treatment (time = 0). For measurements of the spine/shaft fluorescence ratio in the time-lapse experiments shown in [Figure 2](#fig02){ref-type="fig"}, fluorescence measurements at each time point were performed by manually drawing around the area of interest and normalizing to its membrane area. The change in fluorescence (Δ*F*) was normalized to the averaged fluorescence intensity (*F*~0~) before kainate treatment. Δ*F* was calculated for each frame by subtraction of *F*~0~ from the measured fluorescence intensity at each time point.

FRAP and FRAP-FLIP
------------------

FRAP and FLIP protocols were performed as described previously [@b9],[@b20],[@b22]. Briefly, photobleaching was achieved by on-demand activation (controlled by acousto-optical tunable filter) of maximal laser power targeted to predefined circular ROIs. Depending on the precise experiment photobleaching lasted ∼1--4 seconds. Images were acquired within 5 seconds of the end of photobleaching. After acquisition the fluorescence data were normalized to correct for any photobleaching during the sampling. This was done by analysing a region in a different cell remote from the specifically photobleached ROI. Background bleaching was never more than 10% of the total fluorescence. Each FRAP dataset was then expressed as a percentage of prebleach fluorescence (average of five images immediately before photobleaching) and then fitted to the equation that models Brownian two-dimensional diffusion in a membrane after photobleaching and incorporates the possibility of an immobile population [@b15]. The quality of FRAP plot fitting was estimated by *R*^2^ values. From this fit, the time constant and *R* values were extracted for each experiment. Averaged diffusion coefficients were calculated by applying the equation *D* = *A*^2^/*C t*~1/2~ [@b44], where *D* is the diffusion coefficient, *A* is the area of the membrane in the bleached region for each time point and *C* is a constant value for two-dimensional diffusion. More detailed protocols are published in video format [@b23],[@b24].

Transferrin assay
-----------------

Neurons expressing GFP were preincubated with serum/B27-free neurobasal for 1 h and then incubated with 10 µg/mL of Alexa 594-conjugated transferrin (Molecular Probes) for 10--15 min. Cells were then washed twice and then placed in modified aCSF (see above) at 37°C containing L689560 (5 μM), GYKI 53655 (40 μM) and TTX (0.5 μM) to block NMDARs, AMPARs and suppress activity-dependent release of glutamate, respectively. For live-cell experiments, neurons were recorded for 7--10 min, then 10 μM kainate was applied for 3 min, the neurons washed twice and placed in aCSF without kainate. Sequential sets of z-stacks (0.15-µm spacing between single slices) were acquired in both channels using a spinning disk confocal microscope.

For fixed cells, treatments were performed as described above. In EDTA (0.5 mM) and BAPTA-AM (1 mM) experiments, CaCl~2~ was replaced with NaCl in the aCSF modified media. For PLC and G-protein inhibition, neurons were preincubated with PLC inhibitor U73122 (1 μM) or pertussis toxin (PTX, 0.5 μM) for 10--15 min before the kainate challenge. Following 20-min recovery at 37°C, neurons were washed twice, fixed in 2.0% paraformaldehyde, mounted and imaged. Series of z-stacks (0.15-µm spacing between single confocal slices) were collected by sequential acquisition of the same focal plane in both channels.

GluK2 distribution and colocalization assays
--------------------------------------------

Neurons were treated as described above, fixed in 2.0% paraformaldehyde, permeabilized with 0.05% digitonin and blocked with 5% of horse serum for half an hour and then stained with specific primary antibodies against GluK2 (rabbit polyclonal anti-GluK2 antibody, Millipore) or NR1 (NB100-41105, Novus Biologicals) and Cy3-conjugated secondary antibody (Jackson Laboratory). For PSD95 (clone 7E3-1B8, Millipore) staining cells were treated with methanol for 5 min at −20°C, incubated with the primary antibody and then with Cy5-conjugated secondary antibody (Jackson Laboratory). To assess the distribution of GluK2 in spines/dendrite, neurons were transfected with mCherry or GFP to fill the neuron and define the spines. After 48--72 h neurons were fixed, permeabilized and stained with specific primary antibodies against GluK2 followed by Cy2-conjugated secondary antibodies (The Jackson Laboratory).

Receptor exocytosis experiments
-------------------------------

To measure the insertion of new receptors directly into the spine membrane, we incubated neurons expressing SEP-GluK2 with excess anti-GFP antibody (rAb; 1:200, Invitrogen) at room temperature for 5 min to cross-link SEP-GluK2 and prevent lateral diffusion between the shaft and spine. Neurons were then placed on a microscope stage at 37°C and incubated with diluted anti-GFP rAb directly coupled to Alexa 594 (anti-GFP-Alexa 594, 1:500) for 2 min to visualize the plasma membrane. The neurons were quickly washed twice and the Alexa 594 fluorescence acquired, this was designated as time t = 0. Confocal sensitivity was adjusted to produce the maximum dynamic range of detection while avoiding saturation. Cells were incubated either a further 10 min to allow exocytosis of new receptors to occur and then reprobed with anti-GFP-Alexa 594 (1:200), rapidly washed twice and imaged to determine the SEP-GluK2 inserted during the 10-min incubation interval. Newly inserted receptors were visualized with anti-GFP-Alexa 594 antibody and the rates of insertion in the spine head and in the shaft were calculated as the increase of Alexa-594 fluorescence after 10 min. Note that only the insertion of receptors not labelled during the first anti-GFP-Alexa 594 incubation, but labelled during the second incubation contribute to the increase of fluorescence after 10 min. Thus, this approach allows the quantification of SEP-GluK2 from the intracellular pool (i.e. which had not previously been present at the cell surface) or newly synthesized *de novo* SEP-GluK2. Any reinsertion/recycling of SEP-GluK2 labelled during the first anti-GFP-Alexa 594 incubation did not contribute to the increase of fluorescence after 10 min in this assay. We validated that the GFP antibody preincubation effectively cross-linked surface SEP-GluK2 by demonstrating that there was no FRAP in areas in the shaft and the spine of cells incubated with cycloheximide (see [Figure S1](#SD1){ref-type="supplementary-material"}A--C). The concentration of antibody needed to saturate membrane SEP-GluK2 at *t* = 0 was established by performing an additional incubation with anti-GFP-Alexa595 immediately after the first, without time interval. Saturation was considered when less than 5% of increase in the fluorescence was detected (see [Figure S1](#SD1){ref-type="supplementary-material"}D).

For each pair of spine/dendrites spine and dendrite fluorescence were quantified independently as the increase of fluorescence at *t* = 10 normalized to the fluorescence at *t* = 0. The ratio of insertion was also calculated as surface-expressed SEP-GluK2 at *t* = 10 minus that *t* = 0 in the spine divided by surface-expressed SEP-GluK2 in the dendrite at *t* = 10 minus that at *t* = 0. For control this ratio was 0.907 ± 0.04 and for kainate-stimulated it was 0.905 ± 0.06.

Image analysis and quantification
---------------------------------

Analysis of endosomes localization was performed as previously described [@b30] and blind with respect to the treatment. Briefly, cell-filled images (GFP) and recycling endosome-labelled images (Alexa595) were thresholded at 1.20- to 1.80-fold (for cell-filled images) and at 1.30- to 2.10-fold (for recycling endosome-labelled images) and the image stacks were reassembled into a set of red-green three-dimensional (3D) stereo images (ImageJ, NIH). Endosome localization relative to spines was classified according to the presence of an endosomal structure at the head (a), in the neck (b), in the base (c), head and neck (d) or head, neck and base of the spine. When a portion of the endosome region extended into the dendritic shaft, defined by a perpendicular line drawn at the base of the spine, it was also counted as being present at the base.

Three-dimensional volumes of z-stacks (0.25-µm spacing between single confocal slices) were analysed using ImageJ (NIH). The degree of colocalization between immunolabels was assessed in whole-cell volumes and subvolumes by calculating the Pearson\'s correlation coefficient in the ROI using the JaCoP plugin [@b45]. The Pearson\'s correlation coefficient was calculated for the original data and for a large set (500) of images randomized with a grain size determined by the point spread function of the microscope objective. If the Pearson\'s correlation coefficient of the original image was not greater than 95% of the randomized images, then the samples were not used. Cells displaying saturated or low, near-threshold signals were also discarded. Automated thresholding was used to avoid user bias in setting analysis parameters. Histograms presenting the mean correlation coefficient (derived from 19 to 31 cells assessed per treatment condition) are shown ± standard deviation (SD).

For GluK2 localization in endosomal structures, 3D images were segmented using ImageJ Fiji software and then the analysis of centroids and intensity centres was performed as described [@b45] using the object-based colocalization analysis plugin in ImageJ. Data are shown as percentage of colocalizing structures in both channels ± SD. These percentages were compared to a random distribution by shifting 180° one of the channels and analysing them in the same way.

Analysis of the distribution of fluorescence in the spine and shaft was performed as described elsewhere [@b19] with the specified modifications. All analyses were carried out blind with respect to the treatment condition. Briefly, ROIs were delineated with a box that divided longitudinally the spine and adjacent shaft in half and both halves were quantified. The shaft extension was defined in each pair of spine/shaft by drawing a perpendicular line at the base of the spine equal to the radius of the spine head ([Figure S1](#SD1){ref-type="supplementary-material"}C). The fluorescence profiles across the spine/head pairs were obtained, the peaks of fluorescence intensity were normalized to mCherry fluorescence in each region and the values obtained used to quantify the receptor distribution along the spine and shaft. We repeated the analysis by using averaged fluorescence in the selected areas of the spine and shaft ([Figure S1](#SD1){ref-type="supplementary-material"}D) normalized to mCherry in the same area. Data are presented as histograms of the averaged ratios of the peak values in pairs of spine/shaft ± standard error of the mean (SEM).

Biotinylation
-------------

Treatments were performed at 37°C in modified aCSF (with L689560, GYKI 53655 and TTX) plus the indicated drugs. Neurons were incubated with membrane-impermeant Sulfo-NHS-SS-Biotin (0.15 mg/mL, Pierce) in PBS for 10 min on ice as described previously [@b9]. Cells were lysed, solubilized and centrifuged and supernatants were incubated with streptavidin beads to isolate biotinylated proteins. Tubulin was used as an intracellular control to ensure that there was no biotinylation of intracellular proteins.

Statistical analyses
--------------------

Statistical significance for differences between paired combinations of images was calculated using the two-tailed Student\'s *t*-test. Statistical analysis of differences between experimental groups was performed using one-way [anova]{.smallcaps} followed by *post hoc* Tukey test calculated using SigmaStat software. Data are presented as mean ± SEM.
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Additional Supporting Information may be found in the online version of this article:

**Figure 1. Methods for quantifying GluK2 in spines and controls demonstrating surface cross-linking blocks lateral diffusion of SEP-GluK2.** A) Three-dimensional reconstruction of a dendritic segment from a 17 DIV neuron. B) Two-dimensional projection of a *z*-stack of a dendritic segment filled with GFP and orthogonal view (right panel). PSD95 (left panel, red) was superimposed onto GFP images showing that clusters over the dendrite correspond to spines and protrusion perpendicular to the dendrite in *z* (white arrow). Scale bar = 1 μm. C) Illustration demonstrating the method used for line scan analysis. The spine was bisected in two halves by a longitudinal line through the spine and shaft. A region of shaft equal to half of the diameter of the spine head was analysed (yellow arrows). Fluorescence profiles were constructed from the maximum intensity values for each column of pixels (one of which is illustrated by the yellow vertical box) within the selected area. Scale bar = 0.5 μm. D) Alternative quantification methods using averaged fluorescence intensities within the spine or the dendrite (encompassed with a white line). Bar graph shows the quantification using averaged fluorescence in control and kainate-treated neurons. E and F) Representative FRAP experiments in unstimulated neurons expressing S\'EP-GluK2 and preincubated with cycloheximide and GFP antibodies (1:200) and then with GFP-Alexa595 (1:500). There is little or no FRAP (measured at 600--900 seconds) in spine (E) or dendrite (F) demonstrating that antibody cross-linking of surface GluK2 blocks lateral diffusion. Scale bar = 5 μm. G) Quantification of the SEP-GluK2 recovery after FRAP in the spine and dendrite of untreated cells and cells preincubated with an anti-GFP antibody (GFP) to cross-link surface SEP-GluK2. H) Images demonstrating that saturating concentrations of unlabelled anti-GFP antibody were used to cross-link surface SEP-GluK2. In exocytosis experiments neurons were incubated with unlabelled anti-GFP antibodies (1:100--1:1000), washed twice and then immediately incubated with anti-GFP-Alexa595 antibody (1:500). Fluorescence after the first incubation with anti-GFP-Alexa595 antibody (top) was compared to the fluorescence after the second incubation (bottom). At saturating concentrations of unlabelled anti-GFP antibody, there should be no change between the first and second incubation with anti-GFP-Alexa595 antibody. As expected, a very low signal was detected as denoted by the blue colour. The unlabelled anti-GFP antibody concentration was considered saturated when the increase in the fluorescence of GFP-Alexa595 between the first and the second incubation was lower than 5%. Scale bar = 8 μm.

**Figure 2. The GluK2 increase in spines is not because of surface diffusion.** A) Example of FRAP-FLIP experiment where the region of interest (ROI) was bleached (FRAP, middle panel, white box) and a segment of dendrite proximal to the FRAP ROI was continuously bleached (FLIP, left panel, green box) to prevent any fluorescence recovery from lateral diffusion. B) SEP-GluK2 in spines and shaft inside the ROI of the FRAP-FLIP experiments. Upper panels = control; lower panels = kainate-treated. There is no discernible difference in recovery rates. Scale bar = 2 μm. C) Normalized fluorescence intensity values of spine/shaft pairs of FRAP-FLIP experiments after control (left panel) and kainate (right panel). In both conditions, neurons were preincubated with cycloheximide for 2 h, transferred to the microscope stage and bleached immediately after the kainate treatment (10 μM, 3 min). Data show mean ± SEM, *n* = 16--22 pairs spine/shaft from eight to nine neurons.

**Figure 3. GluK2 increase in spines is independent of Rab4 and Rab8**. A) Representative confocal images of endogenous GluK2 (green) localization in the spine and shaft of neurons expressing RFP-Rab4, RFP-Rab4dn, RFP-Rab8 or RFP-Rab8dn. Scale bar = 1 μm. B) Mean GluK2 intensities through the spine head and shaft in cells expressing RFP-Rab8 or RFP-dominant-negative Rab8 after kainate treatment. p \< 0.001, *n* = 12--22 pairs spine/shaft from 10 to 13 neurons. C) Averaged values of GluK2 intensities through the spine head and shaft in cells expressing RFP-Rab4 or RFP-dominant-negative Rab4 after kainate treatment. p \< 0.001, *n* = 18--28 pairs spine/shaft from 13 to 15 neurons.
